Recursion director Blake Borgeson disposes of 30,000 shares for $97,500

Reuters2026/08/06 21:24

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Recursion Pharmaceuticals director Blake Borgeson sold 30,000 Class A common shares on Aug. 4 at $3.25.
Direct holdings fell to 6,188,287 shares following the sale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001856094-26-000014), on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Apple is negotiating a 3-5 year long-term NAND flash memory contract with Kioxia, potentially without a price cap. This marks a shift in its procurement strategy from "lower prices and multiple sources" to "volume lock-in and long-term contracts." The change is driven by fierce competition among AI data center clients for storage capacity, forcing Apple to prioritize supply security. Pricing power for storage chips is shifting from buyers to sellers, and the duration of this storage cycle may exceed traditional market expectations.

华尔街见闻•2026/09/08 04:46